The Lancet Haematology shared on X:
“NEW-Tranexamic acid did not prevent bleeding in patients with haematological malignancies and severe thrombocytopenia compared to placebo: results from the randomised, double-blind, parallel, phase 3, TREATT trial.
‘Although the overall conclusions… are sound and applicable to a less selected group of patients with thrombocytopenia, the results do not exclude a benefit for the large population of patients with leukaemia’
Linked comment by Charles A Schiffer.”
Authors: Lise J Estcourt et al.
